Assessing the Value of Health Technologies

Understanding the value of new or existing medical tests, therapies, procedures, drugs, devices and prevention techniques is more than knowing their cost.  As health care costs continue to rise at unsustainable rates policymakers, patients, providers, industry, and payers are all challenged to understand the relative value of various diagnostic and treatment options to enable the delivery of effective care at a sustainable cost.

Duke-Margolis, in close collaboration with the Duke Clinical Research Institute, combines experts in patient-centered definitions of value, comparative effectiveness, economic analysis, and downstream system impact to understand why low-value care continues to occur, to establish frameworks for cost-effectiveness analysis, and to develop methodology to measure value from the point of view of different stakeholders across the healthcare system and test ways to communicate value in a meaningful, transparent manner.

Second Panel on Cost-Effectiveness in Health and Medicine
Barriers to Eliminating Low-Value Health Care
Comparing the Effect of Changing Analytic Perspectives on Conclusions About the Relative Value of Care Strategies
Quantifying the Value of Hope in Cancer Care
Value in Health Care Initiative (in partnership with the American Heart Association)